Results 151 to 160 of about 3,310,806 (358)

Circulatory therapeutics: use of antihypertensive agents and their effects on the vasculature

open access: yesJournal of Cellular and Molecular Medicine, 2010
•  Antihypertensive agents ‐  Diuretics ‐  β‐blockers ‐  Calcium channel blockers ‐  Angiotensin converting enzyme inhibitors ‐  Angiotensin receptor blockers ‐  ACEIs versus ARBs versus CCBs versus diuretics ‐  Direct renin inhibitors ‐  a‐adrenergic ...
E. Schiffrin
semanticscholar   +1 more source

Things We Do for No Reason: Failing to consider primary aldosteronism in the initial evaluation of hypertension, hypertensive urgency, and hypertensive emergency

open access: yesJournal of Hospital Medicine, EarlyView.
Abstract Hypertension is frequently treated as essential hypertension. However, secondary causes of hypertension should be considered, because distinct treatments are used for different causes of hypertension. Primary aldosteronism is considered a candidate for the most common cause of secondary hypertension.
Michael C. Shih   +4 more
wiley   +1 more source

Correction to: Association of Antihypertensive Agents with the Risk of In-Hospital Death in Patients with Covid-19. [PDF]

open access: yesCardiovasc Drugs Ther, 2022
Chouchana L   +12 more
europepmc   +1 more source

Prolonged Vancomycin‐Induced Linear IgA Disease in a Patient With Renal Failure

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT A 64‐year‐old man with pneumococcal septic shock and subsequent renal failure underwent treatments with antibiotics including intravenous vancomycin (VCM). Blistering skin lesions appeared 10 days after the initiation of VCM. When the patient was transferred to us 5 months later, blisters with erythema were still observed on the abdomen and ...
Kaori Takezawa   +5 more
wiley   +1 more source

Treatment Selection and Prioritization for the EJS ACT‐PD MAMS Trial Platform

open access: yesMovement Disorders, EarlyView.
Abstract Background There are currently no disease‐modifying therapies (DMTs) registered for Parkinson's disease (PD). The Edmond J. Safra Accelerating Clinical Trials in Parkinson Disease (EJS ACT‐PD) initiative will expedite clinical assessment of putative DMTs through a multi‐arm multistage (MAMS) trial, testing several treatments against a common ...
Cristina Gonzalez‐Robles   +29 more
wiley   +1 more source

On Networks with Active and Passive Agents [PDF]

open access: yesarXiv, 2014
We introduce an active-passive networked multiagent system framework, which consists of agents subject to exogenous inputs (active agents) and agents without any inputs (passive agents), and analyze its convergence using Lyapunov stability.
arxiv  

Increased Collagen Synthesis in Blood Vessels of Hypertensive Rats and Its Reversal by Antihypertensive Agents [PDF]

open access: green, 1974
Akira Ooshima   +4 more
openalex   +1 more source

The Quinoline Photoremovable Group (PPG) Platform—A Medicinal Chemist's Approach for Photocage Development and Applications

open access: yesMedicinal Research Reviews, EarlyView.
ABSTRACT Photoremovable protecting groups (PPGs) offer a straightforward solution for the temporary inactivation of biologically active substrates and their subsequent controlled release by light irradiation. Their relatively easy design and mode of application have made them useful tools for studying dynamic biological processes in vitro and in vivo ...
Bence Kontra   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy